Cost analysis of complexed prostate specific antigen in the diagnosis of prostate cancer

被引：0
|
作者：
Warie, H [1 ]
Annemans, L [1 ]
Oosterlinck, W [1 ]
机构：
[1] State Univ Ghent, HEDM, Meise, NA, Belgium
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61882-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：738 / 738
页数：1
相关论文
共 50 条
  • [41] A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations
    Lein, M
    Kwiatkowski, M
    Semjonow, A
    Luboldt, HJ
    Hammerer, P
    Stephan, C
    Klevecka, V
    Taymoorian, K
    Schnorr, D
    Recker, F
    Loening, SA
    Jung, K
    JOURNAL OF UROLOGY, 2003, 170 (04): : 1175 - 1179
  • [42] The measurement of complexed prostate specific antigen has a better performance than total prostate specific antigen
    Herrmann, M
    Stöckle, M
    Sand-Hill, M
    Hübner, U
    Obeid, R
    Wullich, B
    Loch, T
    Geisel, J
    Herrmann, W
    CLINICAL CHEMISTRY, 2004, 50 (06) : A79 - A80
  • [43] VALUE OF TOTAL PROSTATE SPECIFIC ANTIGEN, COMPLEX PROSTATE SPECIFIC ANTIGEN AND IT IS FORMS OF VOLUME-RELATED IN THE DIAGNOSIS OF PROSTATE CANCER
    Deveci, Koksal
    Comakli, Tamer
    Ustuner, Fusun
    Senturk, Banu Arslan
    Sogut, Erkan
    TURKISH JOURNAL OF UROLOGY, 2008, 34 (04): : 407 - 412
  • [44] Complexed prostate-specific antigen, and complext prostate-specific antigen indices for early detection of prostate cancer in men with total prostate-specific antigen between 2.0 and 4.0 ng/ml
    Reissigl, A
    Remzi, M
    Wiunig, C
    Zlotta, A
    Ravery, V
    Hammerer, P
    Dobronski, P
    Kaisary, A
    Marberger, M
    Djavan, B
    JOURNAL OF UROLOGY, 2003, 169 (04): : 426 - 427
  • [45] Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer
    Okegawa, T
    Noda, H
    Nutahara, K
    Higashihara, E
    EUROPEAN UROLOGY, 2000, 38 (04) : 380 - 387
  • [46] Complexed prostate-specific antigen as a staging tool for prostate cancer: A prospective study in 420 men
    Sokoll, LJ
    Mangold, LA
    Partin, AW
    Epstein, JI
    Bruzek, DJ
    Dunn, W
    Mohr, P
    Wallerson, G
    Chan, DW
    UROLOGY, 2002, 60 (4A) : 18 - 23
  • [47] Study of free and complexed prostate-specific antigen in mice bearing human prostate cancer xenografts
    Buhler, KR
    Corey, E
    Stray, AE
    Vessella, RL
    PROSTATE, 1998, 36 (03): : 194 - 200
  • [48] Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: Results of the prospective multicenter European trial
    Djavan, B
    Remzi, M
    Zlotta, AR
    Ravery, V
    Hammerer, P
    Reissigl, A
    Dobronski, P
    Kaisary, A
    Marberger, M
    UROLOGY, 2002, 60 (4A) : 4 - 9
  • [49] Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis
    Caram, Megan E. V.
    Skolarus, Ted A.
    Cooney, Kathleen A.
    EUROPEAN UROLOGY, 2016, 70 (02) : 209 - 210
  • [50] AN EVALUATION OF PROSTATE-SPECIFIC ANTIGEN IN THE DIAGNOSIS AND TREATMENT OF PROSTATE-CANCER
    STAMEY, TA
    HAY, AR
    MCNEAL, JE
    FREIHA, FS
    YANG, N
    JOURNAL OF UROLOGY, 1987, 137 (04): : A195 - A195
12345